O-Toluidine → HCID 57874503、化合物
反応式
CCN(C(C)C)C(C)C.[C:10]1([CH3:24])[CH:15]=[CH:14][CH:13]=[CH:12][C:11]=1[N:16]1[CH:20]=[C:19]([C:21]([OH:23])=O)[N:18]=[N:17]1.CC1C=CC=CC=1N.C1C=CC2N(O)N=NC=2C=1.CCN=C=NCCCN(C)C.Cl.[NH2:55][CH2:56][C:57]([N:59]1[CH2:64][CH2:63][CH:62]([O:65][C:66]2[CH:71]=[CH:70][CH:69]=[C:68]([C:72]([F:75])([F:74])[F:73])[CH:67]=2)[CH2:61][CH2:60]1)=[O:58]>CN(C=O)C.CO.CCCCCC.O>[O:58]=[C:57]([N:59]1[CH2:60][CH2:61][CH:62]([O:65][C:66]2[CH:71]=[CH:70][CH:69]=[C:68]([C:72]([F:75])([F:73])[F:74])[CH:67]=2)[CH2:63][CH2:64]1)[CH2:56][NH:55][C:21]([C:19]1[N:18]=[N:17][N:16]([C:11]2[CH:12]=[CH:13][CH:14]=[CH:15][C:10]=2[CH3:24])[CH:20]=1)=[O:23]参加物
反応物 6
生成物 1
試薬・触媒・溶媒 4
実験手順
DIPEA (171 mg, 1.32 mmol) was added to a stirred solution of 1-o-tolyl-1H-[1,2,3]triazole-4-carboxylic acid (60 mg, 0.29 mmol) (prepared by the method used for the synthesis of Intermediate 64, starting from 2-methylaniline) in DMF (5 mL) followed by HOBt (44 mg, 0.32 mmol) and EDCI (141 mg, 0.73 mmol). After 2 minutes of stirring, 2-amino-1-[4-(3-trifluoromethyl-phenoxy)-piperidin-1-yl]-ethanone hydrochloride (prepared according to Step 1 and 5 of the General Scheme) (110 mg, 0.32 mmol) was added and the resulting mixture was stirred at ambient temperature overnight. Cold water was then added and the solid was collected. The solid obtained was purified by recrystallisation from a solvent system (3:7:0.2), EtOAc:hexane:MeOH to afford 124 mg (86.17% Yield) 1-o-tolyl-1H-[1,2,3]triazole-4-carboxylic acid {2-oxo-2-[4-(3-trifluoromethyl-phenoxy)-piperidin-1-yl]-ethyl}-amide. LC/MS [M+H]+: 488, 98.68%. 1H NMR (300 MHz, DMSO-d6): δ 9.0 (s, 1H), 8.5 (t, 1H), 7.6-7.48 (m, 4H), 7.48 (m, 1H), 7.36 (t, 3H), 4.9 (m, 1H), 4.3 (d, 2H), 4.0 (s, 1H), 3.8 (s, 1H), 3.6 (m, 2H), 2.2 (s, 3H), 2.1 (t, 2H), 1.7 (s, 1H), 1.6 (s, 1H).
後処理
- customprepared by the method
- additionwas added
- stirringthe resulting mixture was stirred at ambient temperature overnight
- customthe solid was collected
- customThe solid obtained
- customwas purified by recrystallisation from a solvent system (3:7:0.2), EtOAc
出典と根拠
- ORDレコード
- ord-7f3f8abf718f42af95bd4a274c95e38c
- 出典データセット
- uspto-grants-2012_03
- 特許番号
- US08129376B2
反応ノート
読み込み中…